Table 1.
PTX − 3 ≥ 3.0 ng/mL (n = 42) | PTX − 3 < 3.0 ng/mL (n = 75) | P value | |
---|---|---|---|
Male/female | 30/12 | 48/27 | 0.54 |
Age | 59.6 ± 8.5 | 59.4 ± 10.5 | 0.89 |
BMI (m/kg2) | 24.2 ± 2.6 | 24.4 ± 2.3 | 0.62 |
Tobacco use (n, %) | 26 (61.9%) | 26 (34.7) | 0.006 |
Hypertension (n, %) | 19 (45.2%) | 45 (60.0%) | 0.18 |
Diabetes (n, %) | 23 (54.8%) | 38 (50.7%) | 0.70 |
Dyslipidemia (n, %) | 27 (64.3%) | 44 (58.7%) | 0.69 |
Coronary artery disease (n, %) | 5 (11.9%) | 12 (16.0%) | 0.59 |
Atrial fibrillation (n, %) | 9 (21.4%) | 4 (5.3%) | 0.013 |
Cerebrovascular disease (n, %) | 16 (38.1%) | 28 (37.3%) | 0.93 |
DVT (n, %) | 24 (57.1%) | 23 (30.7%) | 0.006 |
Pulmonary disease (n, %) | 23 (54.8%) | 47 (62.7%) | 0.44 |
Tumor (n, %) | 8 (19.0%) | 11 (14.6%) | 0.61 |
Recent operation history (n, %) | 10 (23.8%) | 8 (10.6%) | 0.067 |
Bone fracture (n, %) | 7 (16.7%) | 12 (16.0%) | 0.92 |
Trauma (n, %) | 4 (9.5%) | 9 (12.0%) | 0.77 |
Heart rate (beat/min) | 83.2 ± 18.1 | 76.8 ± 13.1 | 0.03 |
SBP (mmHg) | 124.7 ± 22.6 | 135.9 ± 20.5 | 0.007 |
DBP (mmHg) | 68.4 ± 11.7 | 73.7 ± 10.5 | 0.013 |
Shock or hypotension (n, %) | 10 (23.8%) | 4 (5.3%) | 0.006 |
Right heart insufficiency (n, %) | 20 (47.6%) | 13 (17.3%) | 0.001 |
Respiratory failure (n, %) | 30 (71.4%) | 26 (34.6%) | 0.00 |
cTNT (ng/mL) | 1.43 ± 1.01 | 0.98 ± 0.82 | 0.01 |
NT-proBNP (pg/mL) | 2196.8 ± 1784.7 | 742.0 ± 509.3 | 0.00 |
D-dimer (μg/mL) | 7.78 ± 4.34 | 4.35 ± 2.95 | 0.00 |
GFR (mL/min) | 85.2 ± 10.3 | 87.5 ± 10.7 | 0.29 |
BMI: body mass index; DVT: deep vein thrombosis; SBP: systolic blood pressure; DBP: diastolic blood pressure; cTNT: cardiac troponin T; NT-proBNP: N-terminal pro-B-type natriuretic peptide; GFR: glomerular filtration rate.